Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

COVID-19 Vaccination in Children: An Open Question

Author(s): Giuseppe Campagnani, Flaminia Bardanzellu*, Maria Cristina Pintus, Vassilios Fanos and Maria Antonietta Marcialis

Volume 18, Issue 3, 2022

Published on: 12 April, 2022

Page: [226 - 236] Pages: 11

DOI: 10.2174/1573396318666211220093111

Price: $65

Abstract

Background: A safe and effective vaccine represents the best way to control the COVID-19 pandemic, which has caused more than 4 million deaths to date. Several vaccines have now been approved worldwide, depending on the country. Being administered to healthy people, anti-SARS-CoV-2 vaccines must meet high safety standards, and this is even more important among the pediatric population in which the risk of developing severe disease is significantly lower than adults. However, vaccination of the pediatric population could help in reducing viral spread in the whole population.

Objective: Our narrative review analyzes and discusses the currently available literature on the advantages and disadvantages of COVID-19 vaccination in the pediatric population.

Methods: A bibliographic research was conducted through Pubmed, Read, and Scopus using COVID-19, SARS-CoV-2, immunization, antibody, COVID-19 vaccine efficacy, COVID-19 vaccine safety, children, adolescents, MIS-C, adverse effects as keywords.

Results: Although children are less susceptible to COVID-19 infection, they can develop serious consequences, including multi-inflammatory syndrome. However, any vaccine-related side effects should be evaluated before administering vaccination to children while ensuring complete safety. To date, adverse effects are reported in adolescents and young adults following vaccination; however, these are mostly isolated reports.

Conclusion: Further investigation is needed to establish whether there is indeed a cause-and-effect relationship in the development of vaccine-related adverse effects. However, to date, COVID-19 vaccination is recommended for children and adolescents older than 12 years of age. However, this question is still under debate and involves ethical, political, and social issues.

Keywords: COVID-19, SARS-CoV-2, immunization, antibody, COVID-19 vaccine efficacy, COVID-19 vaccine safety, children, adolescents, MIS-C, adverse effects.

« Previous Next »
Graphical Abstract

[1]
Worldometer: Coronavirus Cases. Available from: https://www.worldometers.info/coronavirus
[2]
Covid-19 Vaccine Tracker. Available from: https://covid19.trackvaccines.org/vaccines
[3]
European Medicines Agency: Science Medicines Health. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/
[4]
Our world in data. Available from: https://ourworldindata.org/Last
[5]
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383(27): 2603-15.
[http://dx.doi.org/10.1056/NEJMoa2034577] [PMID: 33301246]
[6]
Nature. Six months of COVID vaccines: what 1.7 billion doses have taught scientists. Available from: https://www.nature.com/articles/d41586-021-01505-x(Accessed on 04 June 2021).
[7]
Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021; 397(10287): 1819-29.
[http://dx.doi.org/10.1016/S0140-6736(21)00947-8] [PMID: 33964222]
[8]
Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ 2021; 373(1088): n1088.
[http://dx.doi.org/10.1136/bmj.n1088] [PMID: 33985964]
[9]
Frenck RW Jr, Klein NP, Kitchin N, et al. Clinical trial group. safety, immunogenicity, and efficacy of the BNT162b2 covid-19 vaccine in adolescents 2021. 2021; 27 Available from: https://www.accesocovid.com/blog-posts-english/safety-immunogenicity-and-efficacy-of-the-bnt162b2-covid-19-vaccine-in-adolescents/
[10]
European Medicines Agency: Science Medicines Health. First COVID-19 vaccine approved for children aged 12 to 15 in EU. Available from: https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-children-aged-12-15-eu
[11]
European Medicines Agency: Science Medicines Health. 2021.2021. Available from: https://www.ema.europa.eu/en/news/
[12]
Rose K, Grant-Kels JM, Striano P, Neubauer D, Tanjinatus O, Etienne EB. Warp speed for COVID-19 drugs and vaccines – time to re-consider how we use the term ‘children’. Clin Infect Dis 2021; ciab399.
[13]
Pawar R, Gavade V, Patil N, et al. Neonatal multisystem inflammatory syndrome (mis-n) associated with prenatal maternal SARS-CoV-2: a case series. Children (Basel) 2021; 8(7): 572.
[http://dx.doi.org/10.3390/children8070572] [PMID: 34356552]
[14]
Wilson E, Girotto J, Passerrello N, et al. Importance of pediatric studies in SARS-CoV-2 vaccine development. J Pediatr Pharmacol Ther 2021; 26(4): 418-21.
[http://dx.doi.org/10.5863/1551-6776-26.4.418] [PMID: 34035689]
[15]
Mahase E. Covid vaccine could be rolled out to children by autumn. BMJ 2021; 372(723): n723.
[http://dx.doi.org/10.1136/bmj.n723] [PMID: 33727232]
[16]
Han B, Song Y, Li C, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, andomized, controlled, phase ½ clinical trial. Lancet Infect 2021; S1473-3099(21): 319-23.
[17]
Centers for disease cure and prevention. Information for pediatric healthcare providers 2022. 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatrichcp.html #(Accessed on Dec. 30, 2020).
[18]
American academy of pediatrics. Children and COVID-19: state-level data report. Available from: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
[19]
Bellino S, Punzo O, Rota MC, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics 2020; 146(4): e2020009399.
[http://dx.doi.org/10.1542/peds.2020-009399] [PMID: 32665373]
[20]
Rumain B, Schneiderman M, Geliebter A. Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges. PLoS One 2021; 16(3): e0242587.
[http://dx.doi.org/10.1371/journal.pone.0242587] [PMID: 33690600]
[21]
Centers for disease cure and prevention. Risk for COVID-19 infection, hospitalization, and death by age group. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html#print
[22]
Bhuiyan MU, Stiboy E, Hassan MZ, et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis. Vaccine 2021; 39(4): 667-77.
[http://dx.doi.org/10.1016/j.vaccine.2020.11.078] [PMID: 33342635]
[23]
Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A, et al. EPICO-AEP Working Group. Arch Dis Child 2021. 106(11): 1129. (Epub 2021 Apr 30)
[24]
ISS COVID-19 epidemic national update 9 June 2021 - 12:00. Publication date: 11 June 2021. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-soruardia-integrata-COVID-19_9-giugno-2021.pdf
[25]
Zimmermann P, Curtis N. Coronavirus infections in children including covid-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; 39(5): 355-68.
[http://dx.doi.org/10.1097/INF.0000000000002660] [PMID: 32310621]
[26]
Mysore V, Cullere X, Settles ML, et al. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens. Medical 2021; 2(9): 1050-71.e7.
[27]
L’Huillier AG, Torriani G, Pigny F, Kaiser L, Eckerle I. Culture-competent SARS-COV-2 in nasopharynx of symptomatic neonates, children, and adolescents. Emerg Infect Dis 2020; 26(10): 2494-7.
[http://dx.doi.org/10.3201/eid2610.202403] [PMID: 32603290]
[28]
Loomba RS, Villarreal EG, Flores S. Letter by loomba et al regarding article, “acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 Pandemic”. Circulation 2021; 143(10): e755-6.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048968] [PMID: 33683950]
[29]
Wang JG, Zhong ZJ, Mo YF, Wang LC, Chen R. Epidemiological features of coronavirus disease 2019 in children: a meta-analysis. Eur Rev Med Pharmacol Sci 2021; 25(2): 1146-57.
[PMID: 33577071]
[30]
Busa F, Bardanzellu F, Pintus MC, Fanos V, Marcialis MA. COVID-19 and school: to open or not to open, that is the question. the first review on current knowledge. Pediatr Rep 2021; 13(2): 257-78.
[http://dx.doi.org/10.3390/pediatric13020035] [PMID: 34205837]
[31]
Basalely A, Gurusinghe S, Schneider J, et al. Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19. Kidney Int 2021; 100(1): 138-45.
[http://dx.doi.org/10.1016/j.kint.2021.02.026] [PMID: 33675848]
[32]
Uccella S, De Grandis E, De Carli F, et al. Impact of the COVID-19 outbreak on the behavior of families in Italy: a focus on children and adolescents. Front Public Health 2021; 9: 608358.
[http://dx.doi.org/10.3389/fpubh.2021.608358] [PMID: 33614580]
[33]
Racine N, Cooke JE, Eirich R, Korczak DJ, McArthur B, Madigan S. Child and adolescent mental illness during COVID-19: A rapid review. Psychiatry Res 2020; 292: 113307.
[http://dx.doi.org/10.1016/j.psychres.2020.113307] [PMID: 32707216]
[34]
Bloise S, Marcellino A, Testa A, et al. Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults. Eur J Pediatr 2021; 180(11): 3335-42.
[http://dx.doi.org/10.1007/s00431-021-04124-w] [PMID: 34023936]
[35]
Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust t cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 2020; 183(1): 158-168.e14.
[http://dx.doi.org/10.1016/j.cell.2020.08.017] [PMID: 32979941]
[36]
Toh ZQ, Higgins RA, Do LAH, et al. Persistence of SARS-CoV-2-specific igg in children 6 months after infection, Australia. Emerg Infect Dis 2021; 27(8): 2233-5.
[http://dx.doi.org/10.3201/eid2708.210965] [PMID: 34016252]
[37]
Beric-Stojsic B, Kalabalik-Hoganson J, Rizzolo D, Roy S. Childhood immunization and covid-19: an early narrative review. Front Public Health 2020; 8: 587007.
[http://dx.doi.org/10.3389/fpubh.2020.587007] [PMID: 33194993]
[38]
Blumental S, Debré P. Challenges and issues of anti-sars-cov-2 vaccines. Front Med (Lausanne) 2021; 8: 664179.
[http://dx.doi.org/10.3389/fmed.2021.664179] [PMID: 34055838]
[39]
DW. Fact check: How useful are coronavirus vaccines for children and adolescents? Available from: https://www.dw.com/en/fact-check-can-children-receive-the-same-covid-19-vaccines-as-adults/a-57628051
[40]
Lee B, Raszka WV Jr. Covid-19 transmission and children: the child is not to blame. Pediatrics 2020; 146(2): e2020004879.
[http://dx.doi.org/10.1542/peds.2020-004879] [PMID: 32457212]
[41]
Lopez AS, Hill M, Antezano J, et al. Transmission dynamics of covid-19 outbreaks associated with child care facilities - salt lake city, Utah, April-July 2020. MMWR Morb Mortal Wkly Rep 2020; 69(37): 1319-23.
[http://dx.doi.org/10.15585/mmwr.mm6937e3] [PMID: 32941418]
[42]
Szablewski CM, Chang KT, Brown MM, et al. SARS-CoV-2 transmission and infection among attendees of an overnight camp - Georgia, June 2020. MMWR Morb Mortal Wkly Rep 2020; 69(31): 1023-5.
[http://dx.doi.org/10.15585/mmwr.mm6931e1] [PMID: 32759921]
[43]
Laxminarayan R, Wahl B, Dudala SR, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science 2020; 370(6517): 691-7.
[http://dx.doi.org/10.1126/science.abd7672] [PMID: 33154136]
[44]
Auger KA, Shah SS, Richardson T, et al. Association between statewide school closure and covid-19 incidence and mortality in the US. JAMA 2020; 324(9): 859-70.
[http://dx.doi.org/10.1001/jama.2020.14348] [PMID: 32745200]
[45]
Kamidani S, Rostad CA, Anderson EJ. COVID-19 vaccine development: a pediatric perspective. Curr Opin Pediatr 2021; 33(1): 144-51.
[http://dx.doi.org/10.1097/MOP.0000000000000978] [PMID: 33278108]
[46]
Centers for disease cure and prevention: Information for pediatric healthcare providers. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html
[47]
Harris RJ, Hall JA, Zaidi A, Andrews NJ, Dunbar JK, Dabrera G. Effect of vaccination on household transmission of SARS-CoV-2 in England. N Engl J Med 2021; 385(8): 759-60.
[http://dx.doi.org/10.1056/NEJMc2107717] [PMID: 34161702]
[48]
Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 2020; 370: m3249.
[http://dx.doi.org/10.1136/bmj.m3249] [PMID: 32960186]
[49]
Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 2020; 371: m3731.
[http://dx.doi.org/10.1136/bmj.m3731] [PMID: 33082154]
[50]
Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (covid-19) infection admitted to us and canadian pediatric intensive care units. JAMA Pediatr 2020; 174(9): 868-73.
[http://dx.doi.org/10.1001/jamapediatrics.2020.1948] [PMID: 32392288]
[51]
Wong BLH, Ramsay ME, Ladhani SN. Should children be vaccinated against COVID-19 now? Arch Dis Child 2021; 321-5. Available from: https://adc.bmj.com/content/archdischild/early/2021/01/04/archdischild-2020-321225.full.pdf
[52]
Biswas A, Bhattacharjee U, Chakrabarti AK, Tewari DN, Banu H, Dutta S. Emergence of novel coronavirus and covid-19: whether to stay or die out? Crit Rev Microbiol 2020; 46(2): 182-93.
[http://dx.doi.org/10.1080/1040841X.2020.1739001] [PMID: 32282268]
[53]
Brusa M, Barilan YM. Voluntary COVID-19 vaccination of children: a social responsibility. J Med Ethics 2021; 47(8): 543-46.
[http://dx.doi.org/10.1136/medethics-2021-107370.]
[54]
Nature: COVID and schools: the evidence for reopening safely. Available from: https://www.nature.com/articles/d41586-021- 01826-x
[55]
Our World in Data. Coronavirus (COVID-19) Vaccinations. Available from: https://ourworldindata.org/covid-vaccinations?country=GBR
[56]
Medrxiv: REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant. Available from: https://www.medrxiv.org/content/10.1101/2021.06.17.21259103v1
[57]
Statista: Number of new coronavirus (COVID-19) cases in the United Kingdom (UK) since January 2020 (as of November 1, 2021), by date of report. Available from: https://www.statista.com/statistics/1101947/coronavirus-cases-development-uk/
[58]
BBC News: Covid: Infections rising, but vaccines saving lives. Available from: https://www.bbc.com/news/health-57694918
[59]
The Times of India: Children are dying of Covid at an alarming rate in Indonesia. Available from: https://timesofindia.indiatimes.com/world/rest-of-world/children-are-dying-of-covid-%20at-an- alarming-rate-in-indonesia/articleshow/84747251.cms
[60]
Abu-Raddad LJ, Chemaitelly H, Butt AA. National study group for covid-19 vaccination Effectiveness of the BNT162b2 Covid-19 vaccine against the B117 and B1351 variants. N Engl J Med 2021; 385(2): 187-9.
[http://dx.doi.org/10.1056/NEJMc2104974.]
[61]
Effectiveness_of_COVID-19_vaccines_against_hospital_admission_with_the_Delta_B. Available from: https://media.tghn.org/articles/Effectiveness_of_COVID-19_vaccines_against_hospital_admission_with_the_Delta_B._G6gnnqJ.pdf
[62]
Raccomandazioni-sip-a-favore-vaccinations-in-the-pediatric-and-adolescent-range. Available from: https://sip.it/2021/06/21/covid-le-8-raccomandazioni-sip-a-favore-vaccinations-in- the-pediatric-and-adolescent-range/
[63]
The AAP recommends COVID-19 for use for their age. Available from: https://pediatrics.aappublications.org/content/148/2/e2021 052336#:~:text=The%20AAP%20recommends%20COVID% 2D19,for%20use%20for%20their%20age
[64]
Nabavi N. Long covid: How to define it and how to manage it. Long covid 2020; 370: m3489.
[http://dx.doi.org/10.1136/bmj.m3489] [PMID: 32895219]
[65]
Wong TL, Weitzer DJ. Long covid and myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs)-a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021; 57(5): 418.
[http://dx.doi.org/10.3390/medicina57050418] [PMID: 33925784]
[66]
ChaolinHLixueHYemingW6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet 2021; 397(10270): 220-32.
[67]
Asadi-Pooya AA, Nemati H. Shahisavandi. M.; Akbari, A.; Emami, A.; Lotfi, M.; Rostamihosseinkhani, M.; Barzegar, Z.; Kabiri, M.; Zeraatpisheh, Z.; Farjoud-Kouhanjani, M.; Jafari, A.; Sasannia, F.; Ashrafi, S.; Nazeri, M.; Nasiri, S. Long COVID in children and adolescents. World J Pediatr 2021; 3: 1-5.
[68]
Stephenson T, Shafran R, De Stavola B, et al. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open 2021; 11(8): e052838.
[http://dx.doi.org/10.1136/bmjopen-2021-052838] [PMID: 34446502]
[69]
LongcovidSos: The impact of COVID vaccination on symptoms of Long Covid. An international survey of 900 people with lived experience. Available from: https://3ca26cd7-266e-4609-b25f- 6f3d1497c4cf.filesusr.com/ugd/8bd4fe_7301ed588cc44d1483e9fc8df7989a03.pdf
[70]
Li J, Hui A, Zhang X, et al. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med 2021; 27(6): 1062-70.
[http://dx.doi.org/10.1038/s41591-021-01330-9] [PMID: 33888900]
[71]
Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 2020; 396(10249): 467-78. [Erratum in: Lancet. 2020 Aug 15;396 [10249 [:466. Erratum in: Lancet. 2020, 396, 1884
[http://dx.doi.org/10.1016/S0140-6736(20)31604-4] [PMID: 32702298]
[72]
Lambert PH, Ambrosino DM, Andersen SR, et al. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine 2020; 38(31): 4783-91.
[http://dx.doi.org/10.1016/j.vaccine.2020.05.064] [PMID: 32507409]
[73]
Graham BS. Rapid COVID-19 vaccine development. Science 2020; 368(6494): 945-6.
[http://dx.doi.org/10.1126/science.abb8923] [PMID: 32385100]
[74]
Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969; 89(4): 422-34.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a120955] [PMID: 4305198]
[75]
Sridhar S, Luedtke A, Langevin E, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med 2018; 379(4): 327-40.
[http://dx.doi.org/10.1056/NEJMoa1800820] [PMID: 29897841]
[76]
MEDPAGE today: Why ADE hasn't been a problem with COVID vaccines. Available from: https://www.medpagetoday.com/special-reports/exclusives/91648
[77]
Aap News. CDC confirms 226 cases of myocarditis after COVID-19 vaccination in people 30 and under. Available from: https://www.aappublications.org/news/2021/06/10/covid-vaccine- myocarditis-rates-061021
[78]
Centers for Disease Cure and Prevention: Myocarditis and Pericarditis After mRNA COVID-19 Vaccination. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html
[79]
COVID-19 Vaccine Safety Updates Vaccines and Related Biological Products Advisory Committee (VRBPAC). Available from: https://www.fda.gov/media/150054/download
[80]
Snapiri O, Rosenberg Danziger C, Shirman N, et al. Transient cardiac injury in adolescents receiving the bnt162b2 mrna covid-19 vaccine. Pediatr Infect Dis J 2021; 40(10): e360-3.
[http://dx.doi.org/10.1097/INF.0000000000003235] [PMID: 34077949]
[81]
Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in 7 adolescents after pfizer-biontech covid-19 vaccination. Pediatrics 2021; 148(3): e2021052478.
[http://dx.doi.org/10.1542/peds.2021-052478] [PMID: 34088762]
[82]
Floyd A, Lal A, Molina K, Puchalski M, Miller D, May L. When lightning strikes twice in pediatrics: case report and review of recurrent myocarditis. Pediatrics 2018; 141(3): e20164096.
[http://dx.doi.org/10.1542/peds.2016-4096] [PMID: 29437909]
[83]
Minocha PK, Better D, Singh RK, Hoque T. Recurrence of acute myocarditis temporally associated with receipt of the mrna covid-19 vaccine in an adolescent male. 2021; 21: 0022-3476.
[84]
Science: Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. Available from: https://www.science.org/news/2021/06/israel-reports-link-between-rare-cases-heart-inflammation-and-covid-19-vaccination
[85]
European Medicines Agency: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis. Available from: https://www.ema.europa.eu/en/news/comirnaty-spikevax- possible-link-very-rare-cases-myocarditis-pericarditis
[86]
Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mrna covid-19 vaccination: what do we know so far? Children (Basel) 2021; 8(7): 607.
[http://dx.doi.org/10.3390/children8070607] [PMID: 34356586]
[87]
The Defender: Pfizer COVID vaccine linked to rare blood clot disorder, Israeli researchers say. Available from: https://childrenshealthdefense.org/defender/pfizer-covid-vaccine-linked-rare-blood-clot-disorder/
[88]
Sørvoll IH, Horvei KD, Ernstsen SL, et al. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination. J Thromb Haemost 2021; 19(7): 1813-8.
[http://dx.doi.org/10.1111/jth.15352] [PMID: 33909350]
[89]
Brito S, Ferreira N, Mateus S, et al. A case of autoimmune hemolytic anemia following covid-19 messenger ribonucleic acid vaccination. Cureus 2021; 13(5): e15035.
[PMID: 34150386]
[90]
Rela M, Jothimani D, Vij M, Rajakumar A, Rammohan A. Auto-immune hepatitis following COVID vaccination. J Autoimmun 2021; 123: 102688.
[http://dx.doi.org/10.1016/j.jaut.2021.102688] [PMID: 34225251]
[91]
European Medicines Agency. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/
[92]
European Medicines Agency. Available from: https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca
[93]
Our World in Data. Coronavirus (COVID-19) Vaccinations. Available from: https://ourworldindata.org/covid-vaccinations
[94]
The Newyork Times. Tracking coronavirus vaccinations around the world. Available from: https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html
[95]
BBC News: Covid: Delay child vaccinations and share jabs with Covax, says WHO. Available from: https://www.bbc.com/news/world-57114734
[96]
BBC News: Vaccinating children before poor morally wrong, Oxford scientist says. Available from: https://www.bbc.com/news/health-57155943
[97]
The Guardian. The pros and cons of giving Covid vaccines to UK children. Available from: https://www.theguardian.com/society/2021/jun/04/the-pros-and-cons-of-giving-covid-vaccines-to-uk- children
[98]
Ultima Ora. Covid: 'in Indonesia muoiono oltre 100 bambini a settimana'. Available from: https://www.ansa.it/sito/notizie/topnews/2021/07/26/covid-in-indonesia-muoiono-oltre-100-bambini-a-settimana_f9acb93a-42d0-4ee8-8169-c7a8305b866e.html
[99]
Faundes V, Pardo R, Cammarata-Scalisi F, Alarcon P, Lay-Son G, San Martin E. Consenso de la rama de genética de la sociedad chilena de pediatría sobre priorización de personas con síndrome de down y otras condiciones poco frecuentes en la campaña de vacunación covid-19. Andes Pediatr 2021; 92(2): 309-15.
[PMID: 34106172]

Rights & Permissions Print Cite
Article Metrics
28
1
© 2024 Bentham Science Publishers | Privacy Policy